| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
THE PAPER BOUTIQUE is a New York, NY-based company in the Business Services sector.
The City of Columbus is a municipal corporation operating under the laws of Ohio. The city government works to maintain a high standard of service and quality of life for all Columbus residents, to keep Columbus neighborhoods vibrant, and to support th...
Visual Communications and Marketing is a Mississauga, ON-based company in the Business Services sector.
Anova Culinary is a San Francisco-based smart kitchen company that provides connected precision cooking appliances, such as a sous vide device for the home cook in 2013 with the Anova One.